Morgan Stanley’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Sell
3,336,626
-75,093
-2% -$2.07M 0.01% 1560
2026
Q1
$75.6M Buy
3,411,719
+412,246
+14% +$9.24M ﹤0.01% 1692
2025
Q4
$67.8M Sell
2,999,473
-10,041
-0.3% -$224K ﹤0.01% 1790
2025
Q3
$66.7M Buy
3,009,514
+206,643
+7% +$4.44M ﹤0.01% 1768
2025
Q2
$58.2M Sell
2,802,871
-121,775
-4% -$2.26M ﹤0.01% 1788
2025
Q1
$51.9M Sell
2,924,646
-22,001
-0.7% -$449K ﹤0.01% 1785
2024
Q4
$61M Sell
2,946,647
-37,775
-1% -$779K ﹤0.01% 1654
2024
Q3
$57.3M Sell
2,984,422
-52,741
-2% -$1.01M ﹤0.01% 1702
2024
Q2
$60.5M Buy
3,037,163
+8,440
+0.3% +$158K ﹤0.01% 1576
2024
Q1
$58.8M Sell
3,028,723
-39,640
-1% -$712K ﹤0.01% 1608
2023
Q4
$51.3M Sell
3,068,363
-495,308
-14% -$8.01M ﹤0.01% 1697
2023
Q3
$58.8M Sell
3,563,671
-238,213
-6% -$4.21M 0.01% 1424
2023
Q2
$68.9M Sell
3,801,884
-265,932
-7% -$4.58M 0.01% 1322
2023
Q1
$76M Sell
4,067,816
-241,400
-6% -$4.24M 0.01% 1226
2022
Q4
$67.4M Sell
4,309,216
-640,905
-13% -$10.9M 0.01% 1278
2022
Q3
$87.3M Sell
4,950,121
-501,874
-9% -$10.3M 0.01% 969
2022
Q2
$107M Sell
5,451,995
-89,599
-2% -$2.1M 0.01% 881
2022
Q1
$163M Sell
5,541,594
-51,684
-0.9% -$1.54M 0.02% 607
2021
Q4
$218M Sell
5,593,278
-142,173
-2% -$5.67M 0.03% 530
2021
Q3
$221M Buy
5,735,451
+91,558
+2% +$3.71M 0.03% 496
2021
Q2
$235M Buy
5,643,893
+51,877
+0.9% +$1.97M 0.03% 489
2021
Q1
$200M Sell
5,592,016
-61,063
-1% -$2.22M 0.03% 482
2020
Q4
$206M Buy
5,653,079
+87,476
+2% +$2.7M 0.03% 465
2020
Q3
$143M Buy
5,565,603
+341,680
+7% +$8.53M 0.03% 479
2020
Q2
$118M Buy
5,223,923
+1,195,751
+30% +$24.3M 0.03% 491
2020
Q1
$67.2M Buy
4,028,172
+1,198,793
+42% +$23.5M 0.02% 619
2019
Q4
$58M Buy
2,829,379
+1,109,777
+65% +$22.2M 0.01% 846
2019
Q3
$35.6M Buy
1,719,602
+1,627,120
+1,759% +$34.6M 0.01% 1072
2019
Q2
$1.92M Buy
+92,482
New +$1.88M ﹤0.01% 3801

Other funds holding BSTZ

Morgan Stanley's BSTZ Position: Q2 2026 in Review

Morgan Stanley reduced its BlackRock Science and Technology Term Trust (BSTZ) stake by 2.2% in Q2 2026, selling an estimated $2.07M and leaving 3,336,626 shares worth $100M. The position accounts for 0.01% of the portfolio, ranked #1560.

Morgan Stanley first reported a position in BSTZ in Q2 2019 and has held it in 29 quarters since. The position peaked at $235M in Q2 2021. 152 funds tracked by Wall St. Rank hold BSTZ as of Q2 2026.

  • Morgan Stanley held 3,336,626 shares of BlackRock Science and Technology Term Trust worth $100M as of Q2 2026.
  • Morgan Stanley sold 75,093 BlackRock Science and Technology Term Trust shares in Q2 2026, an estimated $2.07M.
  • BlackRock Science and Technology Term Trust made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1560 holding.
  • Morgan Stanley first reported a position in BlackRock Science and Technology Term Trust in Q2 2019 and has held it in 29 quarters since.
  • Morgan Stanley's BlackRock Science and Technology Term Trust position peaked at $235M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.